Legal & General Group’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Buy
48,140
+1,185
+3% +$39.8K ﹤0.01% 2014
2026
Q1
$1.69M Sell
46,955
-15,483
-25% -$401K ﹤0.01% 1976
2025
Q4
$1.24M Sell
62,438
-8,240
-12% -$159K ﹤0.01% 2151
2025
Q3
$1.29M Sell
70,678
-1,465
-2% -$24.1K ﹤0.01% 2170
2025
Q2
$1.14M Buy
72,143
+19,322
+37% +$246K ﹤0.01% 2198
2025
Q1
$670K Sell
52,821
-10,518
-17% -$165K ﹤0.01% 2311
2024
Q4
$1.39M Buy
+63,339
New +$1.33M ﹤0.01% 2128

Other funds holding CLMT

Legal & General Group's CLMT Position: Q2 2026 in Review

Legal & General Group increased its Calumet Specialty Products (CLMT) stake by 2.5% in Q2 2026, buying an estimated $39.8K and bringing the position to 48,140 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2014.

Legal & General Group first reported a position in CLMT in Q4 2024 and has held it in 7 quarters since. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Legal & General Group held 48,140 shares of Calumet Specialty Products worth $1.73M as of Q2 2026.
  • Legal & General Group bought 1,185 Calumet Specialty Products shares in Q2 2026, an estimated $39.8K.
  • Calumet Specialty Products made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2014 holding.
  • Legal & General Group first reported a position in Calumet Specialty Products in Q4 2024 and has held it in 7 quarters since.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.